In the wake of news that a coronavirus vaccine has a 90% efficacy in an initial trial under development by pharmaceutical company Pfizer, Ticketmaster has announced a plan to verify the vaccine status of concert-goers before attending concerts. painting Reports.
The proposed system includes the use of Ticketmaster’s digital ticketing app, which will collect information from third-party health information companies (such as Digital Health Pass or IBM’s CLEAR Health Pass) and test providers and vaccine distribution (such as Labcorp or CVS Minute Clinic). The goal is to ensure safety by checking the vaccination status of fans or whether they test negative for COVID-19 within 24 to 72 hours.
Ticketmaster has also developed digital tickets linked to ticket buyer IDs, as well as a SmartEvent system to help enforce social distancing, entry delay and contact tracing. Event organizers will be able to put in place specific preventive protocols, including sanitation, mask compatibility, and social distancing. The company clarified that any health information will be stored with third-party healthcare providers under compliance with HIPPA law and not with Ticketmaster.
The concrete timeline for widespread availability of the vaccine, which is said to be free to the American public, is currently unclear. When reached for comment, Ticketmaster President Mark Jovi told Pitchfork:
Pitchfork has also contacted Live Nation Entertainment representatives regarding potential fees related to Ticketmaster’s COVID-19 Vaccine Status Policy.
Scientists in Germany recently released results of their experiment on transmission of the Corona virus at concerts. The study, which was not peer-reviewed, found that the risk of spreading the Coronavirus in indoor parties is “low to very low” as long as attendees follow hygiene protocols and the place has good ventilation and limited capacity.